(Q36677653)

15 August 2017

1 reference

title

Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials (English)

1 reference

15 August 2017

1 reference

1 reference

Jaskaran B Singh

1

1 reference

PubMed ID

17156156

15 August 2017

Carlos A Zarate

series ordinal

2

1 reference

15 August 2017

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

696-709

1 reference

15 August 2017

6

1 reference

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Psychiatric and medical comorbidities of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Comorbidity in bipolar disorder: a framework for rational treatment selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Risperidone for the treatment of cocaine dependence: randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Lack of efficacy of carbamazepine in the treatment of panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Placebo-controlled study of gabapentin treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-p) ratings in clinical trials of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Quetiapine in bipolar disorder and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00371.X

10.1111/J.1399-5618.2006.00371.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17156156